NCT00462280View on ClinicalTrials.gov

Lovastatin in Treating Patients At High Risk of Melanoma

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

April 30, 2011

Study Completion Date

February 29, 2012

Conditions
Precancerous ConditionStage 0 MelanomaStage I MelanomaStage II Melanoma
Interventions
DRUG

lovastatin

Given PO

OTHER

placebo

Given PO

PROCEDURE

biopsy

Correlative studies

PROCEDURE

laboratory biomarker analysis

Correlative studies

Trial Locations (3)

33612

H. Lee Moffitt Cancer Center and Research Institute, Tampa

84112

Huntsman Cancer Institute, Salt Lake City

92868

University of California Medical Center At Irvine-Orange Campus, Orange

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00462280 - Lovastatin in Treating Patients At High Risk of Melanoma | Biotech Hunter | Biotech Hunter